Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Abbott has option to license TB diagnostic from Inflazyme

April 12, 1996

Sero-Strip HIV-1/2 efficacy demonstrated at CDC

April 12, 1996

Hema-Strip HIV-1/2 approved in Singapore

April 12, 1996

Dusa's ALA for detection of bladder cancer

April 12, 1996

Nuclear matrix proteins for detection of bladder cancer

April 12, 1996

TruQuant BR approved in U.S.

April 12, 1996

Patient enrollment completed for FS069 trial

April 12, 1996

Coronary artery diagnostic to enter clinical studies

April 5, 1996

Alzheimer's diagnostics introduced in U.S.

April 5, 1996

Molecular Biosystems, Shionogi agreement on the rocks

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...